Skip to main content
. 2020 Jul 20;10:11951. doi: 10.1038/s41598-020-68150-8

Figure 4.

Figure 4

Increased TCN1 expression is associated with clinicopathological features, poor prognosis, and chemosensitivity of colon cancer. (a) TCN1 expression in colon cancer and adjacent normal mucosal tissues. (b) Expression status of distinct colon cancer clinical stage and adjacent normal mucosal tissues. (c) Expression of TCN1 in pulmonary metastatic tissues (PMT) and paired normal lung tissues (NLT). (d) Comparison of TCN1 expression in colon cancer and PMT. (e) Expression of TCN1 in left- and right-sided colon cancer. (f) Effect of TCN1 expression level on overall survival. (g) TCN1 expression level was decreased after platinum-containing chemotherapy (pre-chemical therapy vs post-chemical therapy). (h) TCN1 expression in colonoscopy biopsy tissues and specimens resected during surgery. *P < 0.05; **P < 0.01; ***P < 0.001.